Wednesday, March 12, 2008 12:54:31 PM
Cooligy’s breakthrough active microstructure cooling method is the solution resulting in extremely low thermal resistance.
The Cooligy method, originally developed at Stanford University’s mechanical engineering department, uses common materials to produce a closed-loop cooling system for CPUs, ASICS, graphics chips, and the large programmable gate arrays.
The small size, light weight, and excellent thermal performance of the Cooligy system allow tighter packing of components on the circuit board and higher reliability of individual chips as well as the entire system. By contrast, large finned heat sinks or heat pipes based cooling systems are heavy, inefficient and inadequate to the working nerds of next generation of high performance chips.
Cooligy is currently designing and manufacturing products and subsystems for sale to large electronics manufacturers."
http://www.cooligy.com/technology.html
Recent EMR News
- Emerson Schedules Second Quarter 2024 Earnings Release and Conference Call • PR Newswire (US) • 04/17/2024 01:11:00 PM
- Emerson's Next-Generation Software Streamlines Pharmaceutical Development, Accelerates Speed to Market • PR Newswire (US) • 04/16/2024 01:00:00 PM
- Emerson Earns 2024 ENERGY STAR® Partner of the Year Award for Energy Management • PR Newswire (US) • 03/28/2024 04:00:00 PM
- Emerson to Provide Integrated Hydrogen Mobility Technologies to H2 Hauler • PR Newswire (US) • 03/11/2024 01:00:00 PM
- Emerson to Present at J.P. Morgan's 2024 Industrials Conference • PR Newswire (US) • 03/06/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:26:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 04:55:42 PM
- Emerson Sees Boundless Automation™ as Industry Inflection Point to Address Data Barriers & Modernize Operations • PR Newswire (US) • 02/27/2024 09:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:50:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:21:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:11:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 06:40:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 07:51:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:46:46 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:04:31 PM
- Emerson to Present at Citi's 2024 Global Industrial Tech and Mobility Conference • PR Newswire (US) • 02/13/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:06:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:10:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:04:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:55:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:49:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:44:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:36:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:24:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM